Mixed infections in genotypic drug-resistant Mycobacterium tuberculosis
Abstract Tuberculosis disease (TB), caused by Mycobacterium tuberculosis, is a major global public health problem, resulting in more than 1 million deaths each year. Drug resistance (DR), including multi-drug (MDR-TB), is making TB control difficult and accounts for 16% of new and 48% of previously...
Main Authors: | Linfeng Wang, Susana Campino, Jody Phelan, Taane G. Clark |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-44341-x |
Similar Items
-
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
by: Gary Napier, et al.
Published: (2023-01-01) -
A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis
by: Wouter Deelder, et al.
Published: (2022-01-01) -
Robust detection of point mutations involved in multidrug-resistant Mycobacterium tuberculosis in the presence of co-occurrent resistance markers.
by: Julian Libiseller-Egger, et al.
Published: (2020-12-01) -
Machine Learning Predicts Accurately Mycobacterium tuberculosis Drug Resistance From Whole Genome Sequencing Data
by: Wouter Deelder, et al.
Published: (2019-09-01) -
Characterisation of drug-resistant Mycobacterium tuberculosis mutations and transmission in Pakistan
by: Gary Napier, et al.
Published: (2022-05-01)